5-methoxy-n,n-diisopropyltryptamine has been researched along with 5-methoxytryptamine in 32 studies
| Studies (5-methoxy-n,n-diisopropyltryptamine) | Trials (5-methoxy-n,n-diisopropyltryptamine) | Recent Studies (post-2010) (5-methoxy-n,n-diisopropyltryptamine) | Studies (5-methoxytryptamine) | Trials (5-methoxytryptamine) | Recent Studies (post-2010) (5-methoxytryptamine) |
|---|---|---|---|---|---|
| 34 | 0 | 10 | 685 | 7 | 67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.13) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (65.63) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, MF; Shulgin, AT | 1 |
| Muller, AA | 1 |
| Kiyota, K | 1 |
| Alder, JF; Brandt, SD; Fleet, IA; Freeman, S; McGagh, P | 1 |
| Sklerov, JH; Vorce, SP | 1 |
| McGeorge, F; Meatherall, R; Smolinske, S; Wilson, JM | 1 |
| Ikeda, N; Inoue, H; Ishida, T; Kiyoshima, A; Kudo, K; Tsuji, A | 1 |
| Honda, K; Kamata, HT; Kamata, T; Katagi, M; Miki, A; Nishikawa, M; Shima, N; Tanaka, E; Tsuchihashi, H; Zaitsu, K | 1 |
| Honda, K; Kamata, T; Katagi, M; Tanaka, E; Tsuchihashi, H | 1 |
| Coop, A; Eckler, JR; Fantegrossi, WE; Harrington, AW; Kiessel, CL; Rabin, RA; Rice, KC; Winter, JC; Woods, JH | 1 |
| Asanuma, M; Funada, M; Hanioka, N; Ishikawa, T; Kiryu, K; Kumamoto, T; Naito, S; Narimatsu, S; Saito, K; Takaya, K; Yamamoto, S; Yonemoto, R; Yoshida, Y | 1 |
| Alatrash, G; Majhail, NS; Pile, JC | 1 |
| Compton, DM; Larkins, KD; Selinger, MC; Testa, EK | 1 |
| Hidaka, Y; Ichikawa, S; Kihara, M; Kimura, H; Koyano, J; Ono-Kihara, M; Urao, M; Yasuo, T | 1 |
| Campbell, NG; Herring, NR; Lipton, JW; McCrea, AE; Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
| Abe, Y; Arai, M; Hobo, M; Inoue, K; Itokawa, M; Iwata, K; Jitoku, D; Sasaki, T; Shintani, M; Sugihara, G; Takahashi, M; Uno, M; Yasuda, I | 1 |
| Asanuma, M; Fujino, A; Funada, M; Kitayama, S; Ohyama, K; Sogawa, C; Sogawa, N; Tagawa, J | 1 |
| Asanuma, M; Hanioka, N; Ishikawa, T; Kamata, T; Katagi, M; Katsu, T; Kumamoto, T; Masuda, K; Naito, S; Narimatsu, S; Tsuchihashi, H; Yamano, S; Yonemoto, R | 1 |
| Rastogi, R; Schenkel, S; Smolinske, SC | 1 |
| Asanuma, M; Funae, Y; Hagino, S; Hanioka, N; Ishikawa, T; Katsu, T; Kazamori, D; Kiryu, K; Kobatake, M; Kumamoto, T; Masuda, K; Naito, S; Narimatsu, S; Yamano, S; Yonemoto, R; Yoshino, M | 1 |
| Kaneko, S; Nakagawa, T | 1 |
| Kuwahara, T; Makie, T; Mori, M; Nakakura, T; Oda, S; Okamoto, G; Sasakawa, A; Takada, K; Uehira, T; Umemoto, A; Yajima, K; Yamamoto, Y; Yoshino, M | 1 |
| Compton, DM; Dietrich, KL; Selinger, MC; Testa, EK | 1 |
| In, MK; Jin, C; Jin, MJ; Kim, JY; Kwon, OS; Yoo, HH | 1 |
| Fuse-Nagase, Y; Nishikawa, T | 1 |
| Gołembiowska, K; Kamińska, K; Kreiner, G; Noworyta-Sokołowska, K; Rogóż, Z | 1 |
| Barneo-Muñoz, M; Fabregat-Safont, D; Hernández, F; Ibáñez, M; Martinez-Garcia, F; Sancho, JV | 1 |
| Górska, AM; Gołembiowska, K; Noworyta-Sokołowska, K | 1 |
| Le, A; Palamar, JJ | 1 |
| Xiang, P; Yan, H; Yan, X; Yu, Z; Zhao, Y | 1 |
| Wu, H; Xiang, P; Yan, H; Yan, X; Yu, Z; Yuan, S; Zhang, S; Zhao, Y | 1 |
| Hagino, Y; Hall, FS; Ikeda, K; Sora, I; Uhl, GR | 1 |
2 review(s) available for 5-methoxy-n,n-diisopropyltryptamine and 5-methoxytryptamine
| Article | Year |
|---|---|
[Latest cases of acute poisoning in clinical practice--5MeO-DIPT and GHB precursor].
Topics: 5-Methoxytryptamine; Acute Disease; Adult; Designer Drugs; Female; Humans; Male; Sodium Oxybate | 2004 |
Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
Topics: 5-Methoxytryptamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Glutamine; Humans; Limbic System; Membrane Potentials; Mesencephalon; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxicity Syndromes; Oocytes; Organ Culture Techniques; Raphe Nuclei; Serotonin; Serotonin Plasma Membrane Transport Proteins; Substance-Related Disorders; Xenopus | 2008 |
30 other study(ies) available for 5-methoxy-n,n-diisopropyltryptamine and 5-methoxytryptamine
| Article | Year |
|---|---|
N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
Topics: 5-Methoxytryptamine; Hallucinogens; Hearing; Humans; Tryptamines | 1980 |
New drugs of abuse update: Foxy Methoxy.
Topics: 5-Methoxytryptamine; Designer Drugs; Hallucinogens; Humans | 2004 |
Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS.
Topics: 5-Methoxytryptamine; Magnetic Resonance Spectroscopy; Mass Spectrometry; Psychotropic Drugs; Spectrometry, Mass, Electrospray Ionization | 2004 |
A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
Topics: 5-Methoxytryptamine; Chromatography, High Pressure Liquid; Dealkylation; Designer Drugs; Gas Chromatography-Mass Spectrometry; Humans; Indicators and Reagents; Phenethylamines; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tryptamines | 2004 |
A foxy intoxication.
Topics: 5-Methoxytryptamine; Adult; Cyclic N-Oxides; Gas Chromatography-Mass Spectrometry; Humans; Hydroxyindoleacetic Acid; Male; Paranoid Disorders; Paresthesia | 2005 |
Sensitive determination of alpha-methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5MeO-DIPT) in whole blood and urine using gas chromatography-mass spectrometry.
Topics: 5-Methoxytryptamine; Gas Chromatography-Mass Spectrometry; Humans; Reproducibility of Results; Tryptamines | 2005 |
Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
Topics: 5-Methoxytryptamine; Adult; Chromatography, Liquid; Dementia; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male | 2006 |
A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
Topics: 5-Methoxytryptamine; Adult; Autopsy; Diagnosis, Differential; Hallucinogens; Homosexuality, Male; Humans; Male; Mass Spectrometry; Poisoning | 2006 |
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Topics: 5-Methoxytryptamine; Animals; Brain; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Male; Mice; Piperazines; Piperidines; Pyridines; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists | 2006 |
Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
Topics: 5-Methoxytryptamine; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Microsomes, Liver; Oxidation-Reduction; Recombinant Proteins | 2006 |
Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
Topics: 5-Methoxytryptamine; Adult; Diagnosis, Differential; Diuretics; Fluid Therapy; Hallucinogens; Humans; Male; Rhabdomyolysis | 2006 |
An examination of the effects of 5-Methoxy-n, n-di(ISO)propyltryptamine hydrochloride (Foxy) on cognitive development in rats.
Topics: 5-Methoxytryptamine; Animals; Cognition; Perceptual Disorders; Random Allocation; Rats; Rats, Long-Evans; Space Perception | 2006 |
Substance use and sexual behaviours of Japanese men who have sex with men: a nationwide internet survey conducted in Japan.
Topics: 5-Methoxytryptamine; Adolescent; Adult; Aged; Amyl Nitrite; Health Knowledge, Attitudes, Practice; Health Surveys; HIV Infections; Homosexuality, Male; Humans; Internet; Japan; Male; Marijuana Abuse; Middle Aged; Periodicals as Topic; Risk-Taking; Substance-Related Disorders; Surveys and Questionnaires; Unsafe Sex | 2006 |
Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
Topics: 5-Methoxytryptamine; Animals; Behavior, Animal; Biogenic Monoamines; Body Temperature; Body Weight; Brain Chemistry; Central Nervous System Stimulants; Corticosterone; Data Interpretation, Statistical; Designer Drugs; Dose-Response Relationship, Drug; Male; Maze Learning; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Swimming | 2007 |
Acute confusional state after designer tryptamine abuse.
Topics: 5-Methoxytryptamine; Adult; Confusion; Designer Drugs; Female; Gas Chromatography-Mass Spectrometry; Glasgow Coma Scale; Humans; Serotonin; Substance-Related Disorders; Tryptamines | 2007 |
5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.
Topics: 5-Methoxytryptamine; Animals; Biogenic Monoamines; Cell Survival; Chlorocebus aethiops; Cocaine; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Synaptosomes | 2007 |
Oxidation of 5-methoxy-N,N-diisopropyltryptamine in rat liver microsomes and recombinant cytochrome P450 enzymes.
Topics: 5-Methoxytryptamine; Animals; beta-Naphthoflavone; Biotransformation; Cytochrome P-450 Enzyme System; Female; Humans; Male; Microsomes, Liver; Oxidation-Reduction; Rats; Rats, Wistar; Recombinant Proteins | 2008 |
Foxy methoxy: a new drug of abuse.
Topics: 5-Methoxytryptamine; Adult; Anti-Anxiety Agents; Catalepsy; Emergency Medical Services; Hallucinations; Humans; Hypertension; Illicit Drugs; Lorazepam; Male; Mydriasis; Poisoning; Tachycardia; Treatment Outcome | 2005 |
The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2.
Topics: 5-Methoxytryptamine; Alcohol Oxidoreductases; Amino Acid Sequence; Amino Acid Substitution; Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P450 Family 2; Enzyme Stability; Gene Expression Regulation; Microsomes; Molecular Structure; Mutation; Oxidation-Reduction; Rats; Saccharomyces cerevisiae | 2008 |
Problems in three Japanese drug users with Human Immunodeficiency Virus infection.
Topics: 5-Methoxytryptamine; Adult; Amyl Nitrite; Antiretroviral Therapy, Highly Active; Asian People; Drug Interactions; HIV Infections; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Seizures; Substance-Related Disorders | 2008 |
5-methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence.
Topics: 5-Methoxytryptamine; Age Factors; Animals; Cognition Disorders; Hallucinogens; Male; Maze Learning; Prosencephalon; Rats; Rats, Long-Evans; Rotarod Performance Test; Serotonin; Spatial Behavior | 2011 |
A quantitative method for simultaneous determination of 5-methoxy-N,N-diisopropyltryptamine and its metabolites in urine using liquid chromatography-electrospray ionization-tandem mass spectrometry.
Topics: 5-Methoxytryptamine; Animals; Chromatography, Liquid; Designer Drugs; Forensic Toxicology; Hallucinogens; Rats; Serotonin; Spectrometry, Mass, Electrospray Ionization | 2011 |
Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N, N-diisopropyltryptamine abuser.
Topics: 5-Methoxytryptamine; Adult; Delusions; Humans; Male; Mental Disorders; Substance-Related Disorders | 2013 |
Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Analysis of Variance; Animals; Corpus Striatum; DNA Damage; Dopamine; Frontal Lobe; Glutamic Acid; Hallucinogens; Illicit Drugs; Male; Microdialysis; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Oxidative Stress; Rats, Wistar; Serotonin | 2016 |
Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.
Topics: 5-Methoxytryptamine; Animals; Biomarkers; Chromatography, High Pressure Liquid; Europe; Illicit Drugs; Male; Mass Spectrometry; Mice | 2017 |
The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.
Topics: 5-Methoxytryptamine; Age Factors; Animals; Learning; Male; Memory; Rats | 2018 |
Trends in DMT and other tryptamine use among young adults in the United States.
Topics: 5-Methoxytryptamine; Female; Hallucinogens; Humans; Male; N,N-Dimethyltryptamine; Prevalence; Substance-Related Disorders; Tryptamines; United States; Young Adult | 2018 |
Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry.
Topics: 5-Methoxytryptamine; Designer Drugs; Gas Chromatography-Mass Spectrometry; Humans; Mass Spectrometry; Serotonin; Substance Abuse Detection | 2020 |
Development of an LC-MS/MS method for determining 5-MeO-DIPT in dried urine spots and application to forensic cases.
Topics: 5-Methoxytryptamine; Chromatography, Liquid; Desiccation; Drug Stability; Forensic Toxicology; Hallucinogens; Humans; Limit of Detection; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2020 |
Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Corpus Striatum; Female; Male; Mice; Mice, Knockout; Microdialysis; Piperazines; Prefrontal Cortex; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins | 2021 |